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Polyphenols are secondary metabolites naturally produced in plants with an estimated 
market size of USD 2.26 billion by 20271. These compounds have several biological 
and potential therapeutic activities such as anti-inflammatory, antioxidant and 
anticancer. However, polyphenols are extracted from plants where they accumulate in 
low amounts over long growth periods. Moreover, a high investment of water, land and 
time is required, and pests and extreme weather cause insecurity in the supply chain. 
In addition, the extraction process is difficult, inefficient, expensive and 
environmentally unfriendly since it requires the separation of other compounds with 
similar chemical structures. Therefore, in the past decade, several efforts have been 
made to produce polyphenols using synthetic biology approaches2–9. The use of 
microbial chassis to produce polyphenols using combinatorial biosynthesis has several 
benefits as it is not limited by plant availability or environmental factors and it is a 
renewable, environmentally friendly and sustainable approach. Herein, we report the 
construction of artificial pathways for the production of curcuminoids and 
furanocoumarins using Escherichia coli as chassis. These compounds can be produced 
from the amino acid tyrosine or hydroxycinnamic acids (coumaric acid, ferulic acid) 




Curcuminoids pathway involves 6 enzymes: tyrosine ammonia lyase (TAL), 4-
coumarate 3-hydroxylase (C3H), caffeic acid O-methyltransferase (COMT), 4-
coumarate-CoA ligase (4CL), diketide-CoA synthase (DCS), and curcumin synthase 
(CURS1) (Figure 1). Curcuminoids pathway was divided in two modules, the first 
module included TAL, C3H and COMT and the second one 4CL, DCS and CURS1 
and they were optimized separately. The genes were cloned in the Duet plasmids from 
Novagen. In a first approach, each gene of the module was cloned in a single plasmid. 
However, to reduce the metabolic burden, the three genes of each module were 
distributed in two plasmids. After optimizing both modules by testing different 
induction approaches and plasmids, curcumin and other curcuminoids were produced 
from tyrosine (using the whole pathway) in mono-culture. Subsequently, the potential 
of a co-culture approach was evaluated to further improve curcuminoids production by 
reducing cells metabolic burden. We used one E. coli strain able to convert tyrosine to 
ferulic acid and another able to convert the hydroxycinnamic acids produced by the 
first one to curcuminoids. To follow the co-culture population using the blue-white 
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screening method, we used CRISPR-Cas9 tool to disrupt the β-galactosidase gene in 
one of the strains.  
Regarding furanocoumarins pathway, the first steps are the same as the ones in the 
curcuminoids pathway with TAL and 4CL enzymes that convert tyrosine to coumaroyl-
CoA. Then coumaroyl-CoA 2’-hydroxylase (C2’H) can be used to produce several 
coumarins (Figure 1). The expression of prenyltransferase (PT) and psoralen synthase 
(PS) enzymes from furanocoumarins pathway was also studied and engineered. 
 
 
Figure 1: Biosynthetic pathway for curcuminoids and furanocoumarins production. 4CL, 4-coumarate-
CoA ligase; C2’H, coumaroyl-CoA 2’-hydroxylase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic 
acid O-methyltransferase; CURS1, curcumin synthase 1; DCS, diketide-CoA synthase; MS, marmesin 




In this study, we did a step-by-step optimization of the curcuminoids biosynthetic 
pathway. Firstly, we divided the pathway in two modules. The first module contained 
the genes of the pathway that converted tyrosine to ferulic acid and the second one 
contained the genes that converted the hydroxycinnamic acids to curcuminoids. The 
optimization of the two modules of the pathway led to the production of 1325.1 µM of 
ferulic acid and 1529.5 µM of pure curcumin, the highest concentrations ever reported 
(Figure 2a and Figure 2b, respectively). Curcumin was obtained from ferulic acid with 
a percent yield of 100%. Afterwards, the biosynthetic pathway was assembled and 
curcumin and other curcuminoids were produced from tyrosine in mono-culture 
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(Figure 3a). Using this strategy, the curcumin (16.6 µM) and total curcuminoids (19 






















Figure 2: Hydroxycinnamic acids and curcuminoids production by E. coli. (A) Hydroxycinnamic acids 
production by E. coli from tyrosine and carrying pCDFduet_TAL and pRSFduet_C3H_COMT or 
pRSFduet_TAL_C3H and pACYCduet_COMT. (B) Curcumin production by E. coli ∆lacZ from ferulic 
acid and carrying pCDFduet_DCS and pRSFduet_CURS1_4CL or pACYCduet_4CL and 
pRSFduet_CURS1_DCS. TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, 
caffeic acid O-methyltransferase; 4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS1, 
curcumin synthase 1. 
 
Since this production was still low, we tested a co-culture strategy that led to 6.6 times 
increase of total curcuminoids (125.8 µM) as compared to the mono-culture system 
(Figure 3b). The curcuminoids production from tyrosine using this co-culture approach 
corresponds to a 6817% enhancement7,8. Firstly, co-culture population was followed 
by the production of curcuminoids that conferred a yellow/orange color to one of the 
cultures. However, the colors were difficult to distinguish when low production was 
obtained. Therefore, CRISPR-Cas9 was used to disrupt lacZ in one of the strains and 
the colonies were screened using the blue-white screening method. Different co-culture 
inoculation ratios were tested and it was observed that when the strain carrying the first 
part of the pathway was inoculated in higher amount the production of curcuminoids 
was favored. Through the co-culture monitoring it was concluded that this strain 
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strains were inoculated in the same proportion, at 63 h of growth the proportion was 

























Figure 3: Curcuminoids production from tyrosine by E. coli. (A) Production of curcuminoids by E. coli 
mono-culture system from tyrosine and carrying pACYCduet_4CL_TAL, pCDFduet_DCS_C3H and 
pRSFduet_CURS1_COMT. (B) Production of curcuminoids by a co-culture system from tyrosine. In 
co-culture A, E. coli carried pCDFuet_TAL and pRSFduet_C3H_COMT and E. coli ∆lacZ carried 
pCDFduet_DCS and pRSFduet_CURS1_4CL. In co-culture B, E. coli carried pRSFduet_TAL_C3H and 
pACYCduet_COMT and E. coli BL21 (DE3) ∆lacZ carried pACYCduet_4CL and 
pRSFduet_CURS1_DCS. Co-culture A was tested using different inoculation ratios (1:1, 2:1 and 1:2). 
TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic acid O-




Based in the curcuminoids pathway, a similar pathway was constructed to produce 
coumarins. The enzymes 4CL and C2’H were used to produce the coumarins 
umbelliferone, scopoletin and esculetin from coumaric acid, ferulic acid and caffeic 
acid, respectively. Glutathione S- transferase tag was used to assist the proper folding 
of C2’H from Ipomoea batatas. However, most of the protein remained as inclusion 
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precursor of furanocoumarins, was the coumarin produced in higher amount (Figure 
4). Umbelliferone production from tyrosine was also obtained (126 µM) by adding 
TAL enzyme to the pathway. More recently, PT and PS protein were engineered in 
order to remove N-terminal sequences correspondent to transit peptides related to 
plastid localization. The sequences were replaced by other sequences known to 
increase protein expression by increasing solubility. Co-expression of chaperones 
(GroESL system) to facilitate furanocoumarins folding is also being tested.  
 
 




To our knowledge, the curcuminoids productions herein obtained correspond to the 
highest titers ever reported. The enormous potential of synthetic biology and modular 
co-culture engineering to produce curcuminoids from tyrosine or other compounds that 
require several enzymatic steps was herein demonstrated. The results obtained 
comprise a significant step towards the large-scale production of these valuable 
compounds. Regarding the furanocoumarins heterologous production, it is still in an 
early stage and has a long way to go. Nevertheless, recent advancements on some of 
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